According to Horizon Therapeutics 's latest financial reports the company's current EPS (TTM) is $1.92. In 2022 the company made an earnings per share (EPS) of $2.28 a decrease over its 2021 EPS that were of $2.35.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $1.92 | -15.79% |
2022 | $2.28 | -2.98% |
2021 | $2.35 | 34.29% |
2020 | $1.75 | -42.43% |
2019 | $3.04 | -1021.21% |
2018 | -$0.33 | -86.9% |
2017 | -$2.52 | 142.31% |
2016 | -$1.04 | -572.73% |
2015 | $0.22 | -105.96% |
2014 | -$3.69 | 57.69% |
2013 | -$2.34 | -7.51% |
2012 | -$2.53 | -86.04% |
2011 | -$18.12 | 0.09% |
2010 | -$18.10 | 59.23% |
2009 | -$11.37 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Pfizer PFE | $1.86 | -3.12% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 636.98% | ๐บ๐ธ USA |
Merck MRK | $1.82 | -5.12% | ๐บ๐ธ USA |
AstraZeneca AZN | $1.98 | 3.39% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $3.71 | 93.28% | ๐ฎ๐ณ India |